New Delhi: The National Technical Advisory Group on Immunisation (NTAGI)’s Standing Technical Sub-Committee (STSC) has approved the use of COVID-19 vaccines Corbevax and Covaxin for children aged between five and 12 years, official sources said on Friday, news agency PTI reported. However, there was no decision on introducing these vaccines in the vaccination programme.
Data of Biological E’s Corbevax and Bharat Biotech’s Covaxin for children aged between five and 12 years were reviewed in the STSC meeting held on June 16. Members decided that the vaccines can be recommended for administration in children. The members, however, were of the view that data of COVID burden and mortality among children is not robust enough to take any decision to begin vaccination of those below 12 years, the report said quoting sources.
The issue is likely to be discussed in the next meeting. India’s drug regulator in April this year had granted emergency use authorisation to Corbevax for those aged five to 12 years and Covaxin for children in the age group of six to 12 years.
Balasore: A young man was allegedly beaten to death on the suspicion of having committed…
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
Sanskriti Talwar Faridkot (Punjab): For the third consecutive year, Balwinder Singh of Mallan village in…
Bhubaneswar: Rain may play spoilsport in Christmas and New Year celebrations in Odisha as the…
New Delhi: Netflix showed the way, Amazon Prime Video is following in their footsteps. Come…
This website uses cookies.